• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤放疗和化疗后发生的急性髓性白血病。

Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma.

作者信息

Jacobs A D, Gale R P

出版信息

Cancer Treat Rep. 1984 Jun;68(6):909-11.

PMID:6587934
Abstract

Patients receiving ionizing radiation therapy or cytotoxic chemotherapy are at increased risk of developing acute myelogenous leukemia. Ten cases of therapy-linked myelogenous leukemia have been reported in patients with sarcoma, and we report here the first case in a patient who received combined-modality therapy for treatment of an osteogenic sarcoma. As treatment for this disease becomes more intensive and survival improves, the incidence of leukemia following therapy for osteogenic sarcoma may increase.

摘要

接受电离辐射治疗或细胞毒性化疗的患者发生急性髓系白血病的风险增加。已有10例肉瘤患者发生与治疗相关的髓系白血病的报道,我们在此报告首例接受综合治疗的骨肉瘤患者发生该病的病例。随着这种疾病的治疗变得更加强化且生存率提高,骨肉瘤治疗后白血病的发病率可能会增加。

相似文献

1
Acute myelogenous leukemia following radiation therapy and chemotherapy for osteogenic sarcoma.骨肉瘤放疗和化疗后发生的急性髓性白血病。
Cancer Treat Rep. 1984 Jun;68(6):909-11.
2
Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).霍奇金淋巴瘤接受放疗及ABVD方案(阿霉素、博来霉素、长春花碱和达卡巴嗪)治疗后发生的急性髓系白血病
Hematol Oncol. 1996 Mar;14(1):29-31. doi: 10.1002/(SICI)1099-1069(199603)14:1<29::AID-HON561>3.0.CO;2-J.
3
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.一项病例对照研究表明,接受霍奇金淋巴瘤联合治疗方案的患者发生急性白血病的风险显著高于单纯接受化疗的患者,且该风险与放疗范围、化疗类型及疗程相关。
Haematologica. 1998 Sep;83(9):812-23.
4
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.以米托蒽醌为基础的大剂量化疗治疗原发性乳腺癌患者后发生的继发性急性白血病。
Bone Marrow Transplant. 2003 Dec;32(12):1153-7. doi: 10.1038/sj.bmt.1704291.
5
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.霍奇金淋巴瘤与成功治疗患者患急性白血病的风险
Haematologica. 1998 Sep;83(9):769-70.
6
Late effects of adjuvant therapy for breast cancer.乳腺癌辅助治疗的晚期效应。
J Natl Cancer Inst Monogr. 1994(16):101-12.
7
[Secondary malignant tumors following treatment of Hodgkin's disease].[霍奇金淋巴瘤治疗后的继发性恶性肿瘤]
Med Radiol (Mosk). 1984 Aug;29(8):24-8.
8
The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.长期副作用的发生率——尤其是霍奇金病治疗后诱发的白血病。
Rays. 1986 May-Aug;11(2):109-13.
9
[Myelosarcoma as the primary manifestation of acute myeloid leukemia].
Klin Padiatr. 1986 May-Jun;198(3):191-3. doi: 10.1055/s-2008-1026876.
10
Myeloid (granulocytic) sarcoma of epididymis as rare manifestation of recurrent acute myelogenous leukemia.附睾髓样(粒细胞性)肉瘤作为复发性急性髓系白血病的罕见表现。
Urology. 2009 May;73(5):1163.e1-3. doi: 10.1016/j.urology.2008.04.016. Epub 2008 Jul 7.

引用本文的文献

1
The maintenance mechanism of hematopoietic stem cell dormancy: role for a subset of macrophages.造血干细胞休眠的维持机制:巨噬细胞亚群的作用。
BMB Rep. 2023 Sep;56(9):482-487. doi: 10.5483/BMBRep.2023-0092.